dataanalysis-iontrap-default script (Bruker Corporation)
Bruker Corporation is a verified supplier 
Bruker Corporation manufactures this product 
90
Structured Review
Bruker Corporation
dataanalysis-iontrap-default script
Dataanalysis Iontrap Default Script, supplied by Bruker Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dataanalysis-iontrap-default+script/dataanalysis+iontrap+default+script/pm31173034-62-10-14
Average 90 stars, based on 1 article reviews
Dataanalysis Iontrap Default Script, supplied by Bruker Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dataanalysis-iontrap-default+script/dataanalysis+iontrap+default+script/pm31173034-62-10-14
Average 90 stars, based on 1 article reviews
dataanalysis-iontrap-default script - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Software:Article Title: Antibacterial mechanism of gold nanoparticles on Streptococcus pneumoniae. Article Snippet: Streptococcus pneumoniae is a causal agent of otitis media, pneumonia, meningitis and severe cases of septicemia.. This human pathogen infects elderly people and children with a high mortality rate of approximately one million deaths per year worldwide.. Antibiotic-resistance of S. pneumoniae strains is an increasingly serious health problem; therefore, new therapies capable of combating pneumococcal infections are indispensable. Modification:Article Title: Antibacterial mechanism of gold nanoparticles on Streptococcus pneumoniae. Article Snippet: Streptococcus pneumoniae is a causal agent of otitis media, pneumonia, meningitis and severe cases of septicemia.. This human pathogen infects elderly people and children with a high mortality rate of approximately one million deaths per year worldwide.. Antibiotic-resistance of S. pneumoniae strains is an increasingly serious health problem; therefore, new therapies capable of combating pneumococcal infections are indispensable. |